I'll admit that when I first heard about using red and near-infrared light in connection with dental implant healing, I was skeptical. “Red light therapy” is one of those phrases that has become so common in consumer wellness that it's easy to dismiss it before looking at the biology behind it.
Then I started learning about photobiomodulation, or PBM. What caught my attention wasn't the device or the light itself, but what researchers are investigating at the cellular level.
For a dentist, that's where the conversation gets much more interesting.
THIS ISN'T ABOUT WARMING THE TISSUE
Photobiomodulation uses specific wavelengths of red and near-infrared light to produce photochemical rather than thermal effects in tissue. The proposed mechanisms involve cellular chromophores absorbing light and initiating changes in cell signaling and mitochondrial activity.
One of the most discussed mechanisms involves cytochrome c oxidase within the mitochondrial respiratory chain. PBM research has examined downstream effects involving ATP production, nitric oxide signaling and reactive oxygen species, which in turn may influence cellular activity involved in tissue repair.
That's a very different proposition from simply shining a red light on a surgical site.
The real question is whether those cellular effects translate into clinically meaningful differences for the patient.
WHY WOULD THIS MATTER IN IMPLANT DENTISTRY?
Think about the biological work taking place after implant surgery. Angiogenesis, inflammatory regulation, fibroblast activity, collagen remodeling and osteoblast activity all contribute to the healing environment you're depending on.
Those are also among the processes being investigated in PBM research. That's why there's interest in its potential use around oral surgery and implant treatment—not as a substitute for sound surgical principles, but as a possible adjunct to them.
The concept also raises an interesting timing question. If the biological response begins immediately and continues long after the patient leaves the office, when would PBM theoretically be most useful?
Before surgery? Immediately afterward? During early soft-tissue healing? Through the osseointegration period?
Researchers and clinicians are still working through those questions.
BIOLOGICALLY PLAUSIBLE DOESN'T MEAN CLINICALLY PROVEN
This distinction matters to me, particularly because PBM has become so heavily marketed to consumers.
A mechanism can make perfect biological sense without proving that a particular protocol improves a particular clinical outcome. Wavelength, irradiance, dose, treatment duration, timing and tissue depth can all affect what is actually delivered.
That's why “Does red light work?” probably isn't a very useful question.
A better question is: Which wavelengths, doses and protocols have evidence for which clinical applications—and where are the limits of that evidence?
That's the conversation I want dentists to hear.
WHAT HAPPENS WHEN THE PATIENT GOES HOME?
Dr. Rahul Desai is going to explore PBM from that clinical and biological perspective at Biology in Dentistry, the free live virtual Dental Summit I'm hosting on Thursday, October 29.
His presentation will examine PBM across the treatment timeline—from pre-operative tissue conditioning through postoperative healing and osseointegration. He'll also discuss structured in-office and provider-directed at-home protocols, including how Redvive is being used to integrate PBM into clinical care.
I'm not interested in telling you that light is the answer. I'm interested in putting the science in front of dentists who are qualified to decide where it belongs in their own clinical thinking.
If that's a conversation you'd like to hear, I'd like you with us on October 29.
To your unstoppable success,
President
eLaunchers.Com